January 6, 2026 · Form 4 insider transaction
Mathew Aby J. sold 405 shares of BioLife Solutions, Inc. at $25.59 per share, a transaction worth $10.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.